ACAshraf Coovadia

Ashraf Coovadia

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ashraf Coovadia has a total of 101 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Children’s Hospitals in Africa Mapping Project (CHAMP) survey: Facilities, equipment, supplies, infrastructure, and capacity to respond to emergencies

    by Vinayak Bhardwaj, Lawrence R. Stanberry, Philip LaRussa, Wilmot James, Maitry Mahida, Aimable Kanyamuhunga, Atnafu Mekonnen Tekleab, Augustine Omoigberale, Crispen Ngwenya, David Musorewegomo, et al.

    The Children’s Hospitals in Africa Mapping Project (CHAMP) survey was developed and implemented to assess the capabilities of some of the best resourced sub-Saharan African hospitals serving children. The aim was to evaluate hospital facilities, infrastructure, equipment, supplies, services, staffing, and readiness to care for children amid public health emergencies. This report analysed a subset of survey questions that characterised the hospitals and assessed facilities, equipment, supplies, infrastructure and capacity to respond to emergencies and outbreaks. Twenty-four sites were recruited. Twenty hospitals from 15 countries completed the survey from 2018 to 2019. This portion of the CHAMP study identified issues with facilities, equipment, supplies, infrastructure, and the capacity to respond to emergencies and infectious disease outbreaks. On a day-to-day basis, most hospitals were operating at or near capacity and frequently experienced power outages and water shortages. Overall, most hospitals were ill-prepared to manage a major disaster or infectious disease outbreak. If countries are to be prepared to deal with current needs as well as to prevent, detect, and rapidly respond to public health threats, hospitals that care for children will require significant investments.


  • Open Access

    The impact of rising ambient temperatures on the mental and physical health of children

    by Caradee Y Wright, Mary Norval, Natasha Naidoo, Muthise Bulani, Ashraf Coovadia, Linda Theron


  • Open Access

    Advocacy in a Collapsing Public Healthcare Sector

    by Tim De Maayer, Ashraf Coovadia

    The last 15 years have seen a decline in public health services with poor performance and outcomes while the disease burden has increased. Many South African healthcare workers, whilst working in the public sector, are increasingly exposed to deteriorating conditions in which they work and are often witnesses to poor practices and suboptimal treatment. A feeling of futility adds to the burden of moral injury caused by these circumstances. South Africa has a tradition of muzzling healthcare workers who speak up and expose any malpractice, but this should not deter us from performing due diligence on our patients’ care. We need to find innovative ways of documenting and reporting health delivery deficiencies, holding people to account, and if the issues are not addressed, following them up with protected disclosure to an appropriate authority.


  • Open Access

    Addressing the migrant gap: maternal healthcare perspectives on utilising prevention of mother to child transmission (PMTCT) services during the COVID-19 pandemic, South Africa

    by Melanie A. Bisnauth, Ashraf Coovadia, Mary Kawonga, Jo Vearey

    The COVID-19 pandemic has interrupted the prevention of mother-to-child transmission of HIV (PMTCT) programming in South Africa. In 2020, it was estimated that there were 4 million cross-border mig...


  • Dietary Inadequacies in HIV‐infected and Uninfected School‐aged Children in Johannesburg, South Africa

    by Stephanie Shiau, Acadia Webber, Renate Strehlau, Faeezah Patel, Ashraf Coovadia, Samantha Kozakowski, Susan Brodlie, Michael T. Yin, Louise Kuhn, Stephen M. Arpadi

    Objectives: The World Health Organization recommends that human immunodeficiency virus (HIV)‐infected children increase energy intake and maintain a balanced macronutrient distribution for optimal growth and nutrition. Few studies have evaluated dietary intake of HIV‐infected children in resource‐limited settings.Methods: We conducted a cross‐sectional analysis of the dietary intake of 220 perinatally HIV‐infected children and 220 HIV‐uninfected controls ages 5 to 9 years in Johannesburg, South Africa. A standardized 24‐hour recall questionnaire and software developed specifically for the South African population were used to estimate intake of energy, macronutrients, and micronutrients. Intake was categorized based on recommendations by the World Health Organization and Acceptable Macronutrient Distribution Ranges established by the IOM.Results: The overall mean age was 6.7 years and 51.8% were boys. Total energy intake was higher in HIV‐infected than HIV‐uninfected children (1341 vs 1196 kcal/day, P = 0.002), but proportions below the recommended energy requirement were similar in the 2 groups (82.5% vs 85.2%, P = 0.45). Overall, 51.8% of the macronutrient energy intake was from carbohydrates, 13.2% from protein, and 30.8% from fat. The HIV‐infected group had a higher percentage of their energy intake from carbohydrates and lower percentage from protein compared with the HIV‐uninfected group. Intakes of folate, vitamin A, vitamin D, calcium, iodine, and selenium were suboptimal for both groups.Conclusions: Our findings suggest that the typical diet of HIV‐infected children and uninfected children in Johannesburg, South Africa, does not meet energy or micronutrient requirements. There appear to be opportunities for interventions to improve dietary intake for both groups.


  • Open Access

    Decreased bone turnover in HIV-infected children on antiretroviral therapy

    by Stephanie Shiau, Michael Yin, Renate Strehlau, Faeezah Patel, Ndileka Mbete, Donald McMahon, Louise Kuhn, Ashraf Coovadia, Stephen Arpadi

    Introduction: Lower bone mineral content (BMC) has been reported in HIV-infected children, as well as those on ritonavir-boosted lopinavir (LPV/r)-based antiretroviral therapy (ART). Older studies of children with HIV report increased bone resorption, but data with current antiretroviral regimens are limited. Methods: This analysis presents data from the CHANGES Bone Study (Johannesburg, South Africa). Whole body (WB) BMC was assessed by dual-energy X-ray absorptiometry. BMC Z-scores adjusted for sex, age, and height were generated. C-telopeptide of type-1 collagen (CTx), procollagen type-1 N-terminal propeptide (P1NP), and osteocalcin were analyzed. Outcomes were compared between HIV-infected (N=219) and HIV-uninfected children (N=180), as well as between HIV-infected children previously randomized to switch to efavirenz (N=106) versus remain on LPV/r (N=113) (intent-to-treat). Results: The 219 HIV-infected children (49% male) and 180 HIV-uninfected children (55% male) were 5–9 years of age (mean 6.7 years). HIV-infected children were on treatment for a mean of 5.7 years and mean CD4% was 37%; 94% had viral suppression (HIV-1 RNA Z-score was lower in HIV-infected than uninfected children (−0.95 vs −0.79, P=0.05) as well as in children on LPV/r versus efavirenz (−1.20 vs −0.68, PPPP=0.22). CTX (1.70 vs 1.75, P=0.5) and P1NP (585 vs 583, P=0.9) were similar in HIV-infected children on LPV/r versus efavirenz, but osteocalcin was higher in children on LPV/r than efavirenz (72.4 vs 55.6, P<0.01). Bone turnover markers were not strongly correlated with bone mass. Conclusions: Compared to uninfected controls, HIV-infected children in South Africa had lower BMC and lower markers of bone resorption (CTX) and bone formation (P1NP) in contrast to older studies. Although children on LPV/r had higher bone formation (osteocalcin), bone mass was decreased compared those on efavirenz. Longitudinal studies with broader measures of bone turnover are needed to understand the impact of HIV and antiretroviral medications on the dynamics of bone modeling and remodeling during childhood. Disclosure: The authors declared no competing interests.


  • Open Access

    Patterns of Growth, Body Composition, and Lipid Profiles in a South African Cohort of Human Immunodeficiency Virus-Infected and Uninfected Children: A Cross-Sectional Study

    by Sarah M Ramteke, Stephanie Shiau, Marc Foca, Renate Strehlau, Francoise Pinillos, Faeezah Patel, Avy Violari, Afaaf Liberty, Ashraf Coovadia, Louise Kuhn, et al.

    Prior research in sub-Saharan Africa reports dyslipidemia in perinatally human immunodeficiency virus (HIV)-infected children receiving ritonavir-boosted lopinavir (LPV/r) compared with efavirenz; however, interpretation of findings is limited by lack of comparison data from HIV-uninfected children. We conducted a cross-sectional analysis of lipid profiles and growth within a larger longitudinal cohort study of perinatally HIV-infected and HIV-uninfected children aged 4–9 years in Johannesburg, South Africa. At enrollment, anthropometrics, viral load, CD4, total cholesterol (TC), high-density lipoprotein, low-density lipoprotein (LDL), and triglycerides were measured. Weight-for-age Z-score (WAZ), height-for-age Z-score (HAZ), and body mass index-for-age Z-score (BAZ) were calculated. United States pediatric thresholds for dyslipidemia were used. Five hundred fifty-three HIV-infected and 300 HIV-uninfected children (median age 6.9 years) of similar demographic characteristics were enrolled. Of the HIV-infected children, 94.8% were on combination antiretroviral therapy (cART) (65.4% on LPV/r- and 28.6% on efavirenz-based regimens). Among the treated, 94.3% had a viral load P < .01) and HAZ (−1.1 vs −0.7, P < .01) compared with HIV-uninfected children. A lower proportion of HIV-infected children were overweight (BAZ >1) compared with HIV-uninfected children (14.4% vs 21.7%, P = .04). Whether on LPV/r or efavirenz, a higher proportion of HIV-infected children had borderline/elevated TC or abnormal triglycerides than HIV-uninfected children, although a higher proportion of those on LPV/r had borderline/elevated TC, borderline/elevated LDL, or abnormal triglycerides than those on efavirenz. In a South African cohort of HIV-infected children and population-appropriate HIV-uninfected children, unfavorable alterations in lipid profiles were detected in HIV-infected children regardless of treatment regimen compared with HIV-uninfected children. The HIV-infected children were of smaller size than HIV-uninfected children, but there was a high prevalence of overweight in both groups. Strategies for optimizing growth and early life management of lipid alterations may be warranted.


  • The use of dried blood spot specimens for HIV-1 drug resistance genotyping in young children initiating antiretroviral therapy

    by Anna T. Salimo, Johanna Ledwaba, Ashraf Coovadia, Elaine J. Abrams, Karl-Günter Technau, Louise Kuhn, Lynn Morris, Gillian M. Hunt


  • Open Access

    “I get hungry all the time”: experiences of poverty and pregnancy in an urban healthcare setting in South Africa

    by Fiona Scorgie, Duane Blaauw, Tessa Dooms, Ashraf Coovadia, Vivian Black, Matthew Chersich

    For pregnancy to result in a healthy mother and infant, women require adequate nutrition and to be able to access antenatal care, both of which require finances. While most women working in the formal sector in South Africa obtain some form of maternity leave, unemployed women receive no such support. Additional interventions in the form of expanded social assistance to vulnerable pregnant women are needed. To help inform such an approach, we undertook a series of qualitative interviews with low-income pregnant women in Johannesburg. Qualitative, in-depth interviews were held with 22 pregnant women at a public sector antenatal clinic in Johannesburg in 2011 to gather data on their greatest needs and priorities during pregnancy, their access to financial resources to meet these needs, and the overall experience of poverty while pregnant. A total of 22 women were interviewed, 5 of whom were primagravid. One woman was in the first trimester of pregnancy, while nine were almost full-term. All but one of the pregnancies were unplanned. Most participants (15/22) were unemployed, two were employed and on paid maternity leave, and the remaining five doing casual, part-time work. In most cases, pregnancy reduced participants’ earning potential and heightened reliance on their partners. Women not living with the father of their children generally received erratic financial support from them. The highest monthly expenses mentioned were food, accommodation and transport costs, and shortfalls in all three were reportedly common. Some participants described insufficient food in the household, and expressed concern about whether they were meeting the additional dietary requirements of pregnancy. Preparing for the arrival of a new baby was also a considerable source of anxiety, and was prioritized even above meeting women’s own basic needs. Though pregnancy is a normal life occurrence, it has the potential to further marginalise women and children living in already vulnerable households. Extending the Child Support Grant to include the period of pregnancy would not only serve to acknowledge and address the particular challenges faced by poor women, but also go some way to securing the health of newborn children and future generations.


  • Open Access

    Genetic Changes in HIV-1 Gag-Protease Associated with Protease Inhibitor-Based Therapy Failure in Pediatric Patients

    by Jennifer Giandhari, Adriaan E. Basson, Ashraf Coovadia, Louise Kuhn, Elaine J. Abrams, Renate Strehlau, Lynn Morris, Gillian M. Hunt

    Studies have shown a low frequency of HIV-1 protease drug resistance mutations in patients failing protease inhibitor (PI)-based therapy. Recent studies have identified mutations in Gag as an alternate pathway for PI drug resistance in subtype B viruses. We therefore genotyped the Gag and protease genes from 20 HIV-1 subtype C-infected pediatric patients failing a PI-based regimen. Major protease resistance mutations (M46I, I54V, and V82A) were identified in eight (40%) patients, as well as Gag cleavage site (CS) mutations (at codons 373, 374, 378, 428, 431, 449, 451, and 453) in nine (45%) patients. Four of these Gag CS mutations occurred in the absence of major protease mutations at PI failure. In addition, amino acid changes were noted at Gag non-CS with some predicted to be under HLA/KIR immune-mediated pressure and/or drug selection pressure. Changes in Gag during PI failure therefore warrant further investigation of the Gag gene and its role in PI failure in HIV-1 subtype C infection.